Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-3.74M -2.05M -1.73M -11.22M -8.39M -2.68M -2.2M -2.63M -1.45M 6.16M -1.21M -1.17M -1.83M -6.62M -3.86M -3.04M -2.47M -2.61M
Depreciation & Amortization
14.44K 7.22K 7.22K 20.7K 7.22K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.07K 3.81K 642.00
Stock-Based Compensation
224.33K 223.46K 47.57K 96.28K 57.09K 32.09K 32.09K 32.1K 59.44K 32.09K 32.36K 40.67K 90.19K 137.89K 105.91K 131.32K 131.32K 102.33K
Other Working Capital
313.21K -820.74K 244.57K -3.08M 6.25M -448.23K 201.19K 622.54K -394.68K -196.57K 151.29K -157.23K -1.43M 1.37M 1.29M 534.05K -1.1M -100.75K
Other Non-Cash Items
1.06M -153.26K 22.44K 3.17M -4.24K -68.43K -52.31K -29.6K -423.24K -7.74M -716.01K 503.59K 647.08K 14.96K 14.65K 14.35K 14.06K 9.33K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -15.89K -62.96K n/a n/a 716.01K -503.59K -647.08K n/a n/a n/a n/a n/a
Change in Working Capital
517.05K -820.74K -2.1M -1.32M 5.85M -126.47K 229.91K 965.9K -185.9K -27.77K 221.5K -607.62K -1.97M 1.63M 854.66K 658.11K -1.27M 118K
Operating Cash Flow
-1.92M -2.79M -3.75M -9.26M -2.48M -2.84M -2M -1.72M -1.99M -1.58M -947.47K -1.73M -3.71M -4.83M -2.88M -2.23M -3.59M -2.38M
Capital Expenditures
n/a n/a 17.69K -17.69K -19.17K -19.17K n/a n/a n/a n/a n/a n/a n/a n/a 16.15K n/a -49.02K -99.1K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
-281.97K n/a n/a n/a -281.97K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 281.97K n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 301.14K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -281.97K n/a n/a
Investing Cash Flow
-281.97K n/a 17.69K -17.69K n/a -19.17K n/a n/a n/a n/a n/a n/a n/a n/a 16.15K n/a -49.02K -99.1K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -796.88K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a 5K n/a n/a -5K n/a n/a n/a -7.65M -25.7M n/a n/a n/a
Dividend Paid
-3.18M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
6.57M n/a n/a n/a n/a 127.00 n/a n/a n/a 19.00 n/a n/a 7.26M 4.28M 774.35K n/a n/a n/a
Financial Cash Flow
3.39M n/a 3.69M 3.74M n/a 5.42M n/a n/a 15.00 14.02M 5K 4.45M n/a 10.74M -24.92M n/a n/a 8M
Net Cash Flow
1.47M -2.79M -42.03K -5.53M -2.48M 2.56M -2M -1.72M -1.99M 12.45M -942.47K 2.72M -3.71M 5.91M -2.86M -2.23M -3.64M 5.52M
Free Cash Flow
-4.43M -2.79M -3.73M -14.26M -2.5M -2.86M -2M -1.72M -1.99M -1.58M -947.47K -1.73M -3.71M -4.83M -2.86M -2.23M -3.64M -2.48M